Cite
HARVARD Citation
Buonomo, A. et al. (2021). Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies. Expert opinion on drug safety. 20 (10), pp. 1237-1246. [Online].